Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Environmental cues can change the fate and function of epithelial cells, with potential for cell therapy.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Thread-embedding therapy helped hair grow back in mice and might do the same in humans.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

ECM1-modified stem cells can effectively treat liver cirrhosis.

Radiation significantly slows down wound healing in mice.

Adipocytes can change into fibroblast-like cells to help with wound healing.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Vitamin A affects hair loss and immune response in alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Thymic mesenchymal cells have unique gene expression that supports their specific functions in the thymus.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Oral ulcers are common in SLE patients and often link to other symptoms.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

MicroRNA-21 could help diagnose and treat skin fibrosis.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.